Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015Alan S. Coates, Andrew Tutt, Binghe Xu et al.|Annals of Oncology|2015Cited by 1.8k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017Giuseppe Curigliano, Andrew Tutt, Harold J. Burstein et al.|Annals of Oncology|2017Cited by 1.3k
Revision of the American Joint Committee on Cancer Staging System for Breast CancerS. Eva Singletary, Frederick L. Greene, Craig Allred et al.|Journal of Clinical Oncology|2002Cited by 1.2k
Activating ESR1 mutations in hormone-resistant metastatic breast cancerDan R. Robinson, Arul M. Chinnaiyan, Yi-Mi Wu et al.|Nature Genetics|2013Cited by 1.2k
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian CancersCatharine M. Sturgeon, Eleftherios P. Diamandis, Michael J. Duffy et al.|Clinical Chemistry|2008Cited by 1.1k